A cancer vaccine that inhibits expression of immune cells' checkpoint proteins will be tested in people after research in animals showed it is safe and effective when combined with an immunotherapy drug. The vaccine activates both B- and T-cell functions to promote tumor clearance and blocks signaling pathways that enable tumor growth, says researcher Pravin Kaumaya, and the combination therapy produced a complete response in nine of 10 animal models of colon cancer.
Sign up for FBR SmartBrief
Biomedical Research News
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.